Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2025)

Historic Interest Expenses for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $1.9 million.

  • Kestra Medical Technologies' Interest Expenses fell 1795.43% to $1.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.4 million, marking a year-over-year decrease of 541.34%. This contributed to the annual value of $7.7 million for FY2025, which is 2414.13% up from last year.
  • Latest data reveals that Kestra Medical Technologies reported Interest Expenses of $1.9 million as of Q4 2025, which was down 1795.43% from $1.9 million recorded in Q3 2025.
  • Over the past 5 years, Kestra Medical Technologies' Interest Expenses peaked at $2.3 million during Q4 2024, and registered a low of $1.7 million during Q1 2024.